We are live on ! Find out more
CL

Choreo LLC Portfolio holdings

AUM $8.15B
1-Year Est. Return 20.12%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+20.12%
3 Year Est. Return
+59.68%
5 Year Est. Return
+57.89%
10 Year Est. Return
+205.42%
AUM
$6.82B
AUM Growth
+$857M
Cap. Flow
+$521M
Cap. Flow %
7.64%
Top 10 Hldgs %
28.83%
Holding
1,708
New
192
Increased
931
Reduced
413
Closed
80

Top Sells

Rank Stock Value
1
BX icon
Blackstone
BX
+$5.22M
2
LRCX icon
Lam Research
LRCX
+$3.85M
3
BLK icon
Blackrock
BLK
+$3.83M
4
SCHX icon
Schwab US Large- Cap ETF
SCHX
+$3.4M
5
TFC icon
Truist Financial
TFC
+$2.51M

Sector Composition

Rank Sector Weight
1 Technology 12.98%
2 Financials 8.42%
3 Consumer Discretionary 4.66%
4 Healthcare 4.16%
5 Industrials 4.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGR
926
CBRE Global Real Estate Income Fund
IGR
$712M
$482K 0.01%
74,904
-12,669
-14% -$74.8K
RIVN icon
927
Rivian
RIVN
$22.9B
$482K 0.01%
46,184
+8,145
+21% +$117K
SSNC icon
928
SS&C Technologies
SSNC
$17.8B
$482K 0.01%
6,545
+265
+4% +$18.8K
SAN icon
929
Banco Santander
SAN
$194B
$481K 0.01%
99,798
+21,427
+27% +$103K
SGOL icon
930
abrdn Physical Gold Shares ETF
SGOL
$6.92B
$481K 0.01%
18,947
-18
-0.1% -$426
COO icon
931
Cooper Companies
COO
$13.7B
$480K 0.01%
4,434
+593
+15% +$57.7K
MMSI icon
932
Merit Medical Systems
MMSI
$4.43B
$479K 0.01%
4,906
+1,532
+45% +$140K
COLL icon
933
Collegium Pharmaceutical
COLL
$1.14B
$478K 0.01%
12,031
-119
-1% -$4.24K
MMU
934
Western Asset Managed Municipals Fund
MMU
$549M
$477K 0.01%
43,727
+2,459
+6% +$26.2K
MLAB icon
935
Mesa Laboratories
MLAB
$539M
$477K 0.01%
3,660
+663
+22% +$78K
TER icon
936
Teradyne
TER
$54.8B
$476K 0.01%
3,691
+391
+12% +$52.7K
EMD
937
Western Asset Emerging Markets Debt Fund
EMD
$609M
$475K 0.01%
46,543
-2,829
-6% -$27.7K
TRI icon
938
Thomson Reuters
TRI
$39.4B
$475K 0.01%
2,750
-4,226
-61% -$713K
ICSH icon
939
iShares Ultra Short Duration Bond Active ETF
ICSH
$7.97B
$473K 0.01%
9,365
-2,024
-18% -$102K
LAZ icon
940
Lazard
LAZ
$4.37B
$473K 0.01%
9,619
+14
+0.1% +$649
DT icon
941
Dynatrace
DT
$12.1B
$470K 0.01%
+9,020
New +$429K
TPL icon
942
Texas Pacific Land
TPL
$28.9B
$470K 0.01%
1,542
+294
+24% +$80.7K
AXON
943
Axon Enterprise
AXON
$40.5B
$469K 0.01%
+1,176
New +$405K
HOLX
944
DELISTED
Hologic
HOLX
$469K 0.01%
5,821
+523
+10% +$41.8K
WY icon
945
Weyerhaeuser
WY
$17.3B
$469K 0.01%
13,913
-621
-4% -$19.1K
TKR icon
946
Timken Company
TKR
$9.82B
$468K 0.01%
5,577
+1,431
+35% +$118K
BOE icon
947
BlackRock Enhanced Global Dividend Trust
BOE
$662M
$467K 0.01%
41,665
-1,345
-3% -$14.6K
ENR icon
948
Energizer
ENR
$1.44B
$466K 0.01%
14,694
+623
+4% +$18.8K
CIVI
949
DELISTED
Civitas Resources
CIVI
$464K 0.01%
8,964
+972
+12% +$60.2K
ARCC icon
950
Ares Capital
ARCC
$13.5B
$463K 0.01%
22,346
+2,750
+14% +$57.1K

Similar funds

Choreo LLC's Q3 2024 Portfolio in Review

As of Q3 2024, Choreo LLC held 1,708 positions worth $6.82B, up 14% from $5.96B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Choreo LLC deployed $521M of net new capital in Q3 2024, opening 192 new positions and adding to 931 existing holdings. Its largest new stake was MACOM Technology Solutions: 600,230 shares worth $64.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Blackstone, an estimated $5.22M trimmed.

  • Choreo LLC's largest Q3 2024 buy was MACOM Technology Solutions: 600,230 shares worth $64.2M.
  • Choreo LLC added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $43.6M increase.
  • Choreo LLC's biggest Q3 2024 reduction was Blackstone, cutting an estimated $5.22M.
  • Choreo LLC fully exited Lam Research in Q3 2024, selling an estimated $3.85M.
  • Choreo LLC's ten largest holdings make up 29% of its $6.82B portfolio in Q3 2024.
  • Choreo LLC opened 192 new positions and closed 80 in Q3 2024.
  • Choreo LLC's portfolio value rose 14% quarter-over-quarter to $6.82B.

Based on Choreo LLC's 13F filing for Q3 2024, filed 7 Nov 2024.